{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:49:43Z","timestamp":1788922183688,"version":"build-2803163510"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Opioid use has not been shown to improve hospitalized inflammatory bowel disease patient pain scores and may prolong the length of stay (LOS). Additional clinical implications of opioid use, particularly high amounts, in the hospital setting have not yet been explored. We sought to determine how high opioid use impacts clinical outcomes in acute severe ulcerative colitis (ASUC).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In this single-center study, we identified all patients hospitalized with ASUC who received intravenous corticosteroids from July 1, 2014 to December 31, 2021. Clinical outcomes including opioid exposure, cumulative intravenous corticosteroid dose, biologic rescue therapy initiation date, colectomy rate, opioid prescription at discharge, LOS, and hospitalization cost were collected. High opioid use was defined as \u226540 oral morphine equivalents (OMEs) per day. A univariable logistic regression was performed to evaluate the association of high opioid use with ASUC outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>185 eligible hospitalizations for ASUC were evaluated. 75 patients (41%) received opioids during hospitalization, and 20 patients (11%) received \u226540 OMEs\/day. High opioid use was associated with a median 3-day delay in biologic rescue therapy initiation when compared with low\/no opioid use (P\u2005=\u2005.02). 70% of patients with high opioid use received an opioid prescription at discharge compared with 10% of those with low\/no use (P\u2005&amp;lt;\u2005.001). Opioid use was not associated with LOS, duration of corticosteroid therapy, colectomy rate, or hospitalization cost.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Among ASUC hospitalizations, high opioid use was associated with delayed biologic rescue therapy initiation and higher rates of opioid prescriptions at discharge.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ibd\/izae216","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T06:51:05Z","timestamp":1726728665000},"page":"1197-1202","source":"Crossref","is-referenced-by-count":3,"title":["Opioid Use and Outcomes in Patients Hospitalized With Acute Severe Ulcerative Colitis"],"prefix":"10.1093","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7582-9177","authenticated-orcid":false,"given":"Norah","family":"Karlovich","sequence":"first","affiliation":[{"name":"Department of Medicine, University of California San Francisco , San Francisco, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"McConnell","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Palo Alto Medical Foundation , Palo Alto, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Velayos","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Kaiser Permanente San Francisco Medical Center , San Francisco, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3067-8061","authenticated-orcid":false,"given":"Uma","family":"Mahadevan","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, University of California San Francisco , San Francisco, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9335-7137","authenticated-orcid":false,"given":"Sara","family":"Lewin","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, University of California San Francisco , San Francisco, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,9,18]]},"reference":[{"issue":"6","key":"2025051304061812000_CIT0001","doi-asserted-by":"publisher","first-page":"e0156666","DOI":"10.1371\/journal.pone.0156666","article-title":"Pain in IBD patients: very frequent and frequently insufficiently taken into account","volume":"11","author":"Zeitz","year":"2016","journal-title":"PLoS One."},{"issue":"5","key":"2025051304061812000_CIT0002","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.cgh.2020.08.041","article-title":"Opioid use among patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"19","author":"Niccum","year":"2021","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"6","key":"2025051304061812000_CIT0003","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1007\/s10620-019-05906-x","article-title":"Pain in inflammatory bowel disease is not improved during hospitalization: the impact of opioids on pain and healthcare utilization","volume":"65","author":"Berry","year":"2020","journal-title":"Dig Dis Sci."},{"issue":"9","key":"2025051304061812000_CIT0004","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.14309\/ajg.0000000000000806","article-title":"A multimodal intervention using nonopioid analgesics is associated with reduced intravenous opioid exposure among hospitalized patients with inflammatory bowel diseases","volume":"115","author":"Dalal","year":"2020","journal-title":"Am J Gastroenterol."},{"issue":"1","key":"2025051304061812000_CIT0005","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/ibd\/izx020","article-title":"Factors associated with length of stay in veterans with inflammatory bowel disease hospitalized for an acute flare","volume":"24","author":"Kelso","year":"2017","journal-title":"Inflamm Bowel Dis."},{"issue":"6","key":"2025051304061812000_CIT0006","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s00384-021-03852-7","article-title":"Targeted housestaff intervention reduces opioid use without worsening patient-reported pain scores and improves outcomes among patients with IBD: the \u201cIBD pain ladder\u201d","volume":"36","author":"Kaimakliotis","year":"2021","journal-title":"Int J Colorectal Dis."},{"issue":"5","key":"2025051304061812000_CIT0007","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.cgh.2006.03.002","article-title":"Serious infections and mortality in association with therapies for Crohn\u2019s disease: TREAT registry","volume":"4","author":"Lichtenstein","year":"2006","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"4","key":"2025051304061812000_CIT0008","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.cgh.2017.10.022","article-title":"Increasing prescription of opiates and mortality in patients with inflammatory bowel diseases in England","volume":"16","author":"Burr","year":"2018","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"10","key":"2025051304061812000_CIT0009","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1038\/ajg.2014.230","article-title":"The prevalence and predictors of opioid use in inflammatory bowel disease: a population-based analysis","volume":"109","author":"Targownik","year":"2014","journal-title":"Am J Gastroenterol."},{"issue":"12","key":"2025051304061812000_CIT0010","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1093\/ibd\/izz100","article-title":"Opioid use is associated with higher health care costs and emergency encounters in inflammatory bowel disease","volume":"25","author":"Alley","year":"2019","journal-title":"Inflamm Bowel Dis."},{"issue":"1","key":"2025051304061812000_CIT0011","doi-asserted-by":"publisher","first-page":"43","DOI":"10.5217\/ir.2018.16.1.43","article-title":"Quality indicators in inflammatory bowel disease","volume":"16","author":"Berry","year":"2018","journal-title":"Intest Res."},{"issue":"12","key":"2025051304061812000_CIT0012","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1093\/ibd\/izac021","article-title":"The relationship between opioid use and healthcare utilization in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"28","author":"Sheehan","year":"2022","journal-title":"Inflamm Bowel Dis."},{"issue":"5","key":"2025051304061812000_CIT0013","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/ibd.21806","article-title":"Narcotic use for inflammatory bowel disease and risk factors during hospitalization","volume":"18","author":"Long","year":"2012","journal-title":"Inflamm Bowel Dis."},{"issue":"9","key":"2025051304061812000_CIT0014","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/DCR.0b013e3181e7562c","article-title":"Impact of narcotic use on the requirement for colectomy in inpatients with ulcerative colitis","volume":"53","author":"Lian","year":"2010","journal-title":"Dis Colon Rectum."},{"issue":"11","key":"2025051304061812000_CIT0015","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1093\/ibd\/izz066","article-title":"Improving the quality of inpatient ulcerative colitis management: promoting evidence-based practice and reducing care variation with an inpatient protocol","volume":"25","author":"Lewin","year":"2019","journal-title":"Inflamm Bowel Dis."},{"issue":"10","key":"2025051304061812000_CIT0016","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1093\/pm\/pnw255","article-title":"Opioid-induced constipation and bowel dysfunction: a clinical guideline","volume":"18","author":"M\u00fcller-Lissner","year":"2017","journal-title":"Pain Med."},{"issue":"4","key":"2025051304061812000_CIT0017","doi-asserted-by":"publisher","first-page":"263","DOI":"10.12788\/jhm.2980","article-title":"Improving the safety of opioid use for acute non-cancer pain in hospitalized adults: a consensus statement from the society of hospital medicine","volume":"13","author":"Herzig","year":"2018","journal-title":"J Hosp Med."},{"issue":"3","key":"2025051304061812000_CIT0018","doi-asserted-by":"publisher","first-page":"384","DOI":"10.14309\/ajg.0000000000000152","article-title":"ACG clinical guideline: ulcerative colitis in adults","volume":"114","author":"Rubin","year":"2019","journal-title":"Am J Gastroenterol."},{"issue":"4","key":"2025051304061812000_CIT0019","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/apt.12387","article-title":"Infliximab as rescue therapy in hospitalised patients with steroid-refractory acute ulcerative colitis: a long-term follow-up of 211 Swedish patients","volume":"38","author":"Sj\u00f6berg","year":"2013","journal-title":"Aliment Pharmacol Ther."},{"issue":"10","key":"2025051304061812000_CIT0020","doi-asserted-by":"publisher","first-page":"e19019","DOI":"10.7759\/cureus.19019","article-title":"Infliximab rescue in acute severe ulcerative colitis complicated by Clostridium difficile infection: a case series","volume":"13","author":"Markovic","year":"2021","journal-title":"Cureus."},{"issue":"5","key":"2025051304061812000_CIT0021","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s11606-015-3539-4","article-title":"Opioid prescribing at hospital discharge contributes to chronic opioid use","volume":"31","author":"Calcaterra","year":"2016","journal-title":"J Gen Intern Med."},{"issue":"4","key":"2025051304061812000_CIT0022","doi-asserted-by":"publisher","first-page":"243","DOI":"10.12788\/jhm.2930","article-title":"Predictors of long-term opioid use after opioid initiation at discharge from medical and surgical hospitalizations","volume":"13","author":"Mosher","year":"2018","journal-title":"J Hosp Med."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izae216\/59192066\/izae216.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/31\/5\/1197\/59192066\/izae216.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/31\/5\/1197\/59192066\/izae216.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T08:06:23Z","timestamp":1747123583000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/31\/5\/1197\/7761076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,18]]},"references-count":22,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,9,18]]},"published-print":{"date-parts":[[2025,5,12]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izae216","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2024,9,18]]}}}